Acquired channelopathies as contributors to development and progression of multiple sclerosis

Exp Neurol. 2014 Dec:262 Pt A:28-36. doi: 10.1016/j.expneurol.2013.12.006. Epub 2014 Mar 20.

Abstract

Multiple sclerosis (MS), the most frequent inflammatory disease of the central nervous system (CNS), affects about two and a half million individuals worldwide and causes major burdens to the patients, which develop the disease usually at the age of 20 to 40. MS is likely referable to a breakdown of immune cell tolerance to CNS self-antigens resulting in focal immune cell infiltration, activation of microglia and astrocytes, demyelination and axonal and neuronal loss. Here we discuss how altered expression patterns and dysregulated functions of ion channels contribute on a molecular level to nearly all pathophysiological steps of the disease. In particular the detrimental redistribution of ion channels along axons, as well as neuronal excitotoxicity with regard to imbalanced glutamate homeostasis during chronic CNS inflammation will be discussed in detail. Together, we describe which ion channels in the immune and nervous system commend as attractive future drugable targets in MS treatment.

Keywords: CNS inflammation; Experimental autoimmune encephalomyelitis; Ion channels; Multiple sclerosis; Neurodegeneration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Central Nervous System / immunology
  • Central Nervous System / pathology*
  • Channelopathies / complications*
  • Disease Progression
  • Humans
  • Multiple Sclerosis / etiology*